Smithers Rapra, the leading specialist in polymer and composite consultancy, analysis and testing, is pleased to announce that its Shawbury, UK, operation is now a full member of the UK GLP (Good Laboratory Practice) compliance monitoring programme.
The Smithers Rapra test facility has been admitted as a full member to the UK GLP compliance programme for the provision of analytical chemistry data after a general inspection for compliance by the MHRA (Medicines and Healthcare Regulatory Agency). This GLP regulation applies to non clinical studies for the safety and efficacy of chemicals, which include pharmaceuticals.
The decision to gain membership in the GLP compliance programme at Smithers Rapra has been very much driven by the increase in market sector demands over the past few years and demonstrates Smithers' continuing development of quality management systems within its laboratories, ensuring that consistent and reliable results are provided to customers with the quality assurances that they require.
Smithers Rapra's consultancy and operations director Stephen Vinter comments: "This is a great achievement for Smithers Rapra in gaining full membership of the UK GLP compliance programme. We have seen a growing trend with customers requiring specialist testing services and the associated quality system requirements. This demonstrates our investment in the facilities and quality systems, and further improves the scope and delivery of the services we can offer to our existing and prospective clients."
Smithers Rapra's analysis laboratories are equipped with state-of-the-art liquid chromatography/mass spectrometry (LC-MS) and gas chromatography/mass spectrometry (GC-MS) equipment; this is complemented by the addition of GCxGC MS TOF and ICP-OES (Inductive Coupled Plasma Optical Emission Spectrometry).
